Estimating dementia-free life expectancy for Parkinson's patients using Bayesian inference and microsimulation

Biostatistics

Volumn 10, Issue 4, 2009, Pages 729-743

  Van Den Hout, Ardo ^a   Matthews, Fiona E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dementia; Life expectancy; Microsimulation; Multistate model; Random effects; Right censoring; Survival

Indexed keywords

AGED; ARTICLE; BAYES THEOREM; BIOSTATISTICS; DEMENTIA; FEMALE; HUMAN; LIFE EXPECTANCY; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NORWAY; PARKINSON DISEASE; PROBABILITY; RISK FACTOR; STATISTICAL MODEL; VALIDATION STUDY;

AGED; BAYES THEOREM; BIOSTATISTICS; DEMENTIA; FEMALE; HUMANS; LIFE EXPECTANCY; LONGITUDINAL STUDIES; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, STATISTICAL; NORWAY; PARKINSON DISEASE; RISK FACTORS;

EID: 74349092804     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxp027     Document Type: Article

References (25)

1. BROOKS, S. AND GELMAN, A. (1998). Alternative methods for monitoring convergence of iterative simulations. Journal of Computational and Graphical Statistics 7, 434-455.
2. BUTER, T. C., VAN DEN HOUT, A., MATTHEWS, F. E., LARSEN, J. P., BRAYNE, C. AND AARSLAND D. (2008). Dementia and survival in Parkinson's disease\-a twelve year population study. Neurology 70, 1017-1022.
3. CRONIN, K. A., LEGLER, J. M. AND ETZIONI, R. D. (1998). Assessing uncertainty in microsimulation modelling with application to cancer screening interventions. Statistics in Medicine 17, 2509-2523.
4. DE LAU, L. M. L., SCHIPPER, C. M. A., HOFMAN, A., KOUDSTAAL, P. J. AND BRETELER, M. M. B. (2005). Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam study. Archives of Neurology 62, 1265-1269. (Pubitemid 41168354)
5. HALPERN, E. F., WEINSTEIN, M. C., HUNINK, M. G. M. AND GAZELLE, G. S. (2000). Representing both first-and second-order uncertainties by Monte Carlo simulation for groups of patients. Medical Decision Making 20, 314-322.
6. IZMIRLIAN, G., BROCK, D., FERRUCCI, L. AND PHILLIPS, C. (2000). Active life expectancy from annual follow-up data with missing responses. Biometrics 56, 244-248.
7. JACKSON, C. H., SHARPLES, L. D., THOMPSON, S. G., DUFFY, S. W. AND COUTO, E. (2003). Multi-state Markov models for disease progression with classification error. Statistician 52, 193-209.
8. JOHNSON, V. E. (2004). A Bayesian χ2 test for goodness-of-fit. The Annals of Statistics 32, 2361-2384.
9. KAY, R. (1986). A Markov model for analysing cancer markers and disease states in survival studies. Biometrics 42, 855-865.
10. KNEIB, T. AND HENNERFEIND, A. (2008). Bayesian semi parametric multi-state models. Statistical Modelling 8, 169-198.
11. LADITKA, S. B. AND WOLF, A. W. (1998). New methods for analyzing active life expectancy. Journal of Aging and Health 10, 214-241.
12. LIÈVRE, A., BROUARD, N. AND HEATHCOTE, C. (2003). The estimation of health expectancies from cross-longitudinal surveys. Mathematical Population Studies 10, 211-248.
13. NORRIS, J. R. (1997). Markov Chains. Cambridge: Cambridge University Press.
14. O'HAGAN, A., STEVENSON, M. AND MADAN, J. (2007). Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA. Health Economics 16, 1009-1023.
15. PAN, S. L., WU, H. M., YEN, A. M. F. AND CHEN, T. H. H. (2007). A Markov regression random-effects model for remission of functional disability in patients following a first stroke: a Bayesian approach. Statistics in Medicine 26, 5335-5353.
16. PLUMMER, M., BEST, N., COWLES, K. AND VINES, K. (2006). CODA: convergence diagnosis and output analysis for MCMC. R News 6, 7-11.
17. R DEVELOPMENT CORE TEAM (2008). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
18. SALAZAR, J. C., SCHMITT, F. A., YU, L., MENDIONDO, M. M. AND KRYSCIO, R. J. (2007). Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia. Statistics in Medicine 26, 568-580.
19. SHARPLES, L. D. (1993). Use of the Gibbs sampler to estimate transition rates between grades of coronary disease following cardiac transplantation. Statistics in Medicine 12, 1155-1169.
20. SPIEGELHALTER, D. J., ABRAMS, K. R. AND MYLES, J. P. (2004). Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester, UK: Wiley.
21. SPIEGELHALTER, D. J. AND BEST, N. G. (2003). Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Statistics in Medicine 22, 3687-3709.
22. SPIEGELHALTER, D. J., BEST, N. G., CARLIN, B. P. AND VAN DER LINDE, A. (2002). Bayesian measures of model complexity and fit (with discussion). Journal of the Royal Statistical Society, Series B 64, 583-640.
23. THOMAS, A., O'HARA, B., LIGGES, U. AND STURTZ, S. (2006). Making BUGS open. R News 6, 12-17.
24. VAN DEN HOUT, A. AND MATTHEWS, F. E. (2008). A piecewise-constant Markov model and the effects of study design on the estimation of life expectancies in health and ill health. Statistical Methods in Medical Research 18, 145-162.
25. WELTON, N. J. AND ADES, A. D. (2005). Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Medical Decision Making 25, 633-645.